Komori
General Meetings of Shareholders4884Kringle Pharma,Inc.Pharmaceuticals

Notice Regarding the Setting of a Record Date for Convening an Extraordinary General Meeting of Shareholders

The record date for determining the shareholders entitled to exercise voting rights at the extraordinary shareholders meeting scheduled to be held in August 2026 has been set as 30 June 2026. The meeting is expected to consider proposals concerning reductions in stated capital and capital reserve and the disposition of surplus, although the details have not yet been determined.

Worth reading
35Immaterial
Scored from 3 of 4 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Avoiding a definitive answer
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Extraordinary (meeting no. Not disclosed)
Date and timeDuring August 2026 (start time Not disclosed)
Matters for resolution1 item
  1. Reduction in stated capital and capital reserve and disposition of surplus (planned)

Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingExtraordinary (meeting no. Not disclosed)
Date and timeDuring August 2026 (start time Not disclosed)
Matters for resolutionReduction in stated capital and capital reserve and disposition of surplus (planned)
Items this document does not state (3)
Shareholder ProposalDirector nomineePercentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To determine the shareholders entitled to exercise voting rights at the extraordinary shareholders meeting. The details of the proposals to be submitted to the meeting are expected to be determined at a future meeting of the Board of Directors.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Setting of a Record Date for Convening an Extraordinary General Meeting of Shareholders | Kringle Pharma,Inc. (4884) timely disclosure | Komori